Conférences  >  Médecine & Soins de Santé  >  Maladies Infectieuses

Harvard Medical School

This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses—ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases ; Newer antimicrobials and treatment strategies for highly resistant infections; Update on antifungal diagnostics and therapy; Monkeypox: comprehensive updates on epidemiology, testing, vaccination, treatment ; The latest on COVID-19, including long COVID; Prevention and treatment of infection in immunocompromised hosts; State-of-the-art approaches to common infections, including complicated urinary tract and intra-abdominal infections; Musculoskeletal infectious diseases ; Clinical approaches to complex, rare, "don't-miss" infections; New, evolving, and emerging infectious diseases; Infections in persons with substance use disorder; What’s new in HIV prevention and management. As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Harvard Medical School Postgraduate Medical Education;     Tél.: [617-384-8600];     Email.: CEPrograms@hms.harvard.edu

Harvard, infection, comprehensive, CME, Monkeypox, antimicrobials, immunocompromised, antifungal, HIV, resistant infection, antimicrobial stewardship, substance use disorder, emerging infectious diseases, zoonoses, tick-borne, ENT, Vaccines, Zika, EEE, sexually transmitted infections, Hepatitis, MRSA, OPAT, detection, diagnosis, treatment, COVID, COVID-19, STIs, difficile, C-diff, staph

APS e.V.

In der vom Aktionsbündnis Patientensicherheit e. V. initiierten Kampagne #DeutschlandErkenntSepsis setzen wir uns gemeinsam mit unseren Partnern – Sepsis-Stiftung, SepsisDialog der Universitätsmedizin Greifswald, Deutsche Sepsis-Hilfe e. V. und Deutsches Qualitätsbündnis Sepsis – dafür ein, die Bevölkerung sowie das medizinische Personal über Sepsis aufzuklären und Todesfälle zu reduzieren. Sie wird vom Bundesgesundheitsministerium gefördert und steht unter der Schirmherrschaft von Prof. Dr. Karl Lauterbach.

Jetzt startet die Kampagne in die nächste Phase und wir laden Sie herzlich zu unserer hybriden Veranstaltung ein. Unter dem Motto „#DeutschlandErkenntSepsis – Jede:r kann Leben retten!“ diskutieren wir mit den wichtigsten Interessenvertreter:innen aus dem Gesundheitswesen sowie mit Sepsis-Betroffenen über Lösungsansätze. Zudem gehen wir mit Ihnen dazu in den Austausch, wie auch Sie zu einer verbesserten Aufklärung über Sepsis in Deutschland beitragen können.

Die Veranstaltung findet am 11. Mai von 09:30 bis ca. 17:00 Uhr im Hotel Aquino in Berlin statt und ist kostenfrei.

Tél.: [+49 3643 2468 137];     Email.: evelin.lammert@kukm.de

#DeutschlandErkenntSepsis, Aktionsbündnis Patientensicherheit e. V., Sepsis-Stiftung, SepsisDialog, Deutsche Sepsis-Hilfe e.V., Deutsches Qualitätsbündnis Sepsis, Bundesgesundheitsministerium, Sepsis, Aufklärung, Sepsis erkennen, Notfall, Behandlung, Folgen

European Molecular Biology Laboratory | EMBL

BioMalPar XIX will showcase the multidisciplinary nature of malaria research with a programme that welcomes clinical malaria, epidemiological studies, immunology, and evolution and ecology alongside core BioMalPar topics. The programme focuses on early-mid career researchers to help mitigate the effects of the COVID-19 pandemic which have been particularly acute for these stages.

The meeting will explore bacterial pathogens and pathogenesis from multiple perspectives, from cellular mechanisms to interbacterial interactions and community behavior, as well as pathogenesis in the complex milieu of the microbiota. The meeting will also highlight the pathogenic potential of the microbiome and explore microbiota-based and engineered antibacterial/therapeutic approaches.

Pharmacologie et développement des médicaments,    Biologie

Meningitis Research Foundation

Our fourteenth international conference returns to the British Museum in London. The event will bring world leading experts together to share the latest advances and discuss today’s challenges for meningitis and septicaemia. There will be both an in-person and virtual offering.

Email.: amelias@meningitis.org

meningitis, septicaemia, infectious disease, paediatrics, vaccinology, public health, tropical medicine

Pédiatrie, Néonatalogie,    Épidémiologie

This conference regularly attracts over 500 scientists, with representatives from many of the major research groups in this area worldwide. If you want to meet many of your peers in this field, this is the place to go.